Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Luster

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Acta Oncologica (Stockholm, Sweden)|November 23, 2006
Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer managementMarkus Luster
Nuklearmedizin. Nuclear Medicine|February 5, 2020
[Back to the Future - Chances and Challenges for Nuclear Medicine]Markus Luster
Nuklearmedizin. Nuclear Medicine|June 25, 2015
[Thyroid into the focus of attention]Markus Luster
Deutsche Medizinische Wochenschrift (1946)|April 2, 2015
[How are thyroid nodules diagnosed?]Andreas Pfestroff, Markus Luster
Nature Reviews. Clinical Oncology|June 20, 2012
Radiotherapy: radioiodine in thyroid cancer-how to minimize side effectsChristoph Reiners, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2010
Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinomaMassimo Salvatori, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|July 6, 2017
A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapyFrederik A Verburg, Markus Luster
Nature Reviews. Endocrinology|November 28, 2012
Thyroid gland: thyroid surgery and radioiodine ablation-the surgeon's roleMarkus Luster, Thomas J Musholt
Nature Reviews. Endocrinology|November 12, 2016
Thyroid cancer: Redifferentiation - a 'new' option for <sup>131</sup>I-negative DTCFrederik A Verburg, Markus Luster
Nature Reviews. Endocrinology|January 20, 2018
Thyroid cancer: Balancing benefit and risk in TSH management of DTCFrederik A Verburg, Markus Luster
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Acta Oncologica (Stockholm, Sweden)|November 23, 2006
Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer managementMarkus Luster
Nuklearmedizin. Nuclear Medicine|February 5, 2020
[Back to the Future - Chances and Challenges for Nuclear Medicine]Markus Luster
Nuklearmedizin. Nuclear Medicine|June 25, 2015
[Thyroid into the focus of attention]Markus Luster
Deutsche Medizinische Wochenschrift (1946)|April 2, 2015
[How are thyroid nodules diagnosed?]Andreas Pfestroff, Markus Luster
Nature Reviews. Clinical Oncology|June 20, 2012
Radiotherapy: radioiodine in thyroid cancer-how to minimize side effectsChristoph Reiners, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2010
Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinomaMassimo Salvatori, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|July 6, 2017
A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapyFrederik A Verburg, Markus Luster
Nature Reviews. Endocrinology|November 28, 2012
Thyroid gland: thyroid surgery and radioiodine ablation-the surgeon's roleMarkus Luster, Thomas J Musholt
Nature Reviews. Endocrinology|November 12, 2016
Thyroid cancer: Redifferentiation - a 'new' option for <sup>131</sup>I-negative DTCFrederik A Verburg, Markus Luster
Nature Reviews. Endocrinology|January 20, 2018
Thyroid cancer: Balancing benefit and risk in TSH management of DTCFrederik A Verburg, Markus Luster
Pageof 19